THE National Agency for Food and Drug Administration and Control (NAFDAC) has cleared the AstraZeneca vaccine, which arrived in Nigeria on Tuesday, for usage in the country.
The National Primary Health Care Development Agency disclosed this on its Twitter handle, @NphcdaNG, on Friday.
The Tweet read: “After undergoing final assessment by NAFDAC, we have confirmation that they have concluded their final checks with positive results.
“Nigeria can now go ahead and use the 3.924m doses of AstraZeneca vaccines.
#YesToCOVID19Vaccine.”
Recall that AlimoshoToday earlier reported that Nigeria received 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India(SII) and shipped via the COVAX Facility.
When Nigeria took delivery of the vaccine on Tuesday, samples were handed over to NAFDAC for safety review.
With this positive result, NPHCDA can proceed with the vaccination of Nigerians starting with frontline health workers at the treatment centre of the National Hospital, Abuja.
